How Antibiotics Work and Why Antibiotic Resistance Is a Global Crisis
Before antibiotics, a simple scratch could kill you. A child's strep throat could turn into a fatal infection, pneumonia was often a death sentence, and syphilis and tuberculosis devastated entire populations. Then, in 1928, a Scottish bacteriologist returned from vacation to find that a mold had contaminated his petri dishes — and that mold was killing the bacteria around it. That accidental discovery launched the antibiotic age, transformed medicine, and saved hundreds of millions of lives.
But antibiotics are now under threat from a force that could unravel their success: the bacteria themselves. As these microbes evolve defenses against our drugs, we are entering what the World Health Organization calls a "silent pandemic" — antimicrobial resistance, or AMR — that already kills more people each year than HIV or malaria. Understanding how antibiotics work, how bacteria defeat them, and how each of us can help preserve them is one of the most important health stories of our time.
What Antibiotics Are — and What They Are Not
An antibiotic is a substance that kills or inhibits the growth of bacteria. Some are produced naturally by molds and other microorganisms (the original meaning of "antibiotic" was "against life"), while others are synthetic or semi-synthetic compounds engineered in laboratories. The defining feature of a good antibiotic is selective toxicity: it harms bacteria without significantly harming the human host.
The Most Important Distinction: Antibiotics Do Not Work on Viruses
Antibiotics target structures and processes that are unique to bacteria — such as the bacterial cell wall or the bacterial ribosome — and that human cells do not have. Viruses are completely different. They are not cells, they have no cell wall or independent metabolism, and they reproduce only by hijacking the machinery of the cells they infect. This is why antibiotics are useless against colds, the flu, most sore throats, COVID-19, and most acute bronchitis — all of which are viral. Taking an antibiotic for a viral infection provides no benefit, exposes you to side effects, and — critically — fuels antibiotic resistance. This single misunderstanding has caused enormous harm.
Bactericidal vs. Bacteriostatic
Antibiotics fall into two broad functional categories:
- Bactericidal antibiotics kill bacteria outright — for example, by destroying the cell wall so the bacterium bursts.
- Bacteriostatic antibiotics do not kill bacteria but stop them from multiplying, allowing the immune system to finish the job. Once the drug is gone, bacterial growth can resume.
The distinction is not always sharp (some bacteriostatic drugs become bactericidal at higher doses), and both types can be highly effective when used appropriately.
How Antibiotics Work — Five Mechanisms
Antibiotics attack bacteria through several distinct mechanisms, each targeting a structure or process essential for bacterial survival. Because these targets are absent from human cells, the drugs can damage bacteria while leaving our cells largely unharmed.
1. Inhibition of Cell Wall Synthesis
Many bacteria are surrounded by a rigid cell wall made of a mesh-like molecule called peptidoglycan, which protects them from bursting under osmotic pressure. Human cells have no cell wall. Antibiotics such as the beta-lactams (penicillins, cephalosporins, carbapenems) and the glycopeptides (vancomycin) block the enzymes that build and cross-link peptidoglycan. Without a functional wall, the bacterium absorbs water, swells, and bursts. This is the mechanism of the original antibiotic, penicillin.
2. Inhibition of Protein Synthesis
Bacteria build proteins using structures called ribosomes, which are slightly different from human ribosomes. Several classes of antibiotics exploit this difference by binding to bacterial ribosomes and stalling protein production: the tetracyclines, macrolides (such as azithromycin), aminoglycosides (such as gentamicin), chloramphenicol, and lincosamides (such as clindamycin). Without new proteins, the bacterium cannot grow or maintain itself.
3. Inhibition of DNA Replication
The fluoroquinolones (such as ciprofloxacin) target bacterial enzymes called DNA gyrase and topoisomerase IV, which untangle DNA during replication. By blocking these enzymes, the drugs prevent the bacterium from copying its DNA — and therefore from dividing. Human cells use a different version of these enzymes, so they are largely spared.
4. Inhibition of RNA Synthesis
Rifamycins (such as rifampin, used to treat tuberculosis) block the bacterial enzyme RNA polymerase, which transcribes DNA into RNA. Without RNA, the bacterium cannot produce the proteins it needs to survive.
5. Inhibition of Metabolism (Folic Acid Pathway)
The sulfonamides ("sulfa drugs") and trimethoprim block two sequential steps in the bacterial synthesis of folic acid, a vitamin essential for making DNA. Crucially, bacteria must make their own folic acid, while humans obtain it from our diet — so blocking this pathway harms bacteria but not us.
Broad- vs. Narrow-Spectrum
Antibiotics also differ in spectrum of activity. Broad-spectrum antibiotics (such as amoxicillin or ciprofloxacin) kill many different types of bacteria, including both Gram-positive and Gram-negative species. Narrow-spectrum antibiotics target only specific bacteria. Whenever possible, doctors prefer narrow-spectrum drugs because they cause less disruption to the body's normal bacteria and apply less selective pressure for resistance. Identifying the specific bacterium causing an infection (through culture and testing) allows a more targeted choice.
The Discovery of Penicillin — A Lucky Accident
The antibiotic era began with one of the most famous accidents in the history of science.
Fleming, 1928
In September 1928, the Scottish bacteriologist Alexander Fleming returned from a vacation to his messy laboratory at St. Mary's Hospital in London. He noticed that a petri dish of Staphylococcus aureus bacteria had been contaminated by a mold — Penicillium notatum — and that the bacteria around the mold had been destroyed. Fleming realized the mold was producing a substance that killed bacteria, which he named penicillin. He published his findings in 1929, but the discovery attracted little attention at the time.
Florey and Chain — Turning Discovery into Medicine
Penicillin remained a laboratory curiosity until the late 1930s, when the pharmacologist Howard Florey and the biochemist Ernst Chain, working at Oxford University, took up the challenge of isolating, purifying, and producing penicillin in usable quantities. By 1941, they had enough to treat their first human patient, and during World War II, mass production — aided by American industry — made penicillin available to Allied soldiers, saving countless lives from wound infections. Fleming, Florey, and Chain shared the 1945 Nobel Prize in Physiology or Medicine for their work, which launched the modern antibiotic age.
The Golden Age of Antibiotics
Between the 1940s and the 1970s, scientists discovered dozens of new antibiotic classes: streptomycin (the first effective treatment for tuberculosis, 1943), chloramphenicol, tetracycline, erythromycin, vancomycin, and many more. For a time, it seemed humanity might triumph over bacterial infection altogether. But even as Fleming accepted his Nobel Prize, he warned of what was coming: in his 1945 lecture, he cautioned that misuse of penicillin could lead to the rise of resistant bacteria. His warning proved prophetic.
How Bacteria Become Resistant — The Four Mechanisms
Bacteria are extraordinarily adaptable. Faced with an antibiotic, they can evolve resistance through several distinct mechanisms. Critically, resistance arises through Darwinian evolution by natural selection: when an antibiotic is used, sensitive bacteria die, while any bacterium with a resistance advantage survives and multiplies — passing its resistance to its descendants.
1. Enzymatic Inactivation — Destroying the Drug
The most common resistance strategy is to produce enzymes that destroy or inactivate the antibiotic. The classic example is beta-lactamase, an enzyme that cuts the beta-lactam ring of penicillins and related drugs, rendering them useless. Beta-lactamases are the reason most Staphylococcus aureus strains are now resistant to plain penicillin. More troubling are enzymes like NDM-1 (New Delhi metallo-beta-lactamase), which destroy even powerful "last-resort" drugs like carbapenems.
2. Target Modification — Changing the Lock
If an antibiotic works by binding to a specific bacterial target, the bacterium can alter that target so the drug can no longer bind. For example, MRSA (methicillin-resistant Staphylococcus aureus) acquired a new cell-wall-building enzyme (called PBP2a, encoded by the mecA gene) that beta-lactam antibiotics cannot effectively block. Similarly, mutations in the bacterial ribosome can make macrolides and aminoglycosides ineffective.
3. Efflux Pumps — Pumping the Drug Out
Many bacteria build molecular pumps in their membranes that actively expel antibiotics before the drugs can reach their targets. A single efflux pump can sometimes recognize and remove multiple unrelated drugs, producing resistance to several antibiotic classes at once.
4. Reduced Permeability — Closing the Doors
Bacteria can also change their outer membranes, reducing or eliminating the channels (porins) through which antibiotics enter. With fewer entry points, less drug reaches the interior, and the bacterium survives. This is especially common in Gram-negative bacteria, whose outer membrane already acts as a barrier.
Biofilms — Strength in Numbers
Some bacteria form biofilms — dense, sticky communities (on surfaces like catheters, teeth, or wounds) embedded in a protective matrix. Biofilms can be up to 1,000 times more resistant to antibiotics than free-floating bacteria of the same species, because the matrix limits drug penetration and the dormant cells within are less vulnerable to drugs that target actively dividing cells.
How Resistance Spreads — Beyond Simple Mutation
Bacteria do not rely on slow mutation alone. They can acquire ready-made resistance genes from other bacteria through a remarkable process called horizontal gene transfer.
Plasmids, Transposons, and Integrons
Bacteria can share genes on small circular pieces of DNA called plasmids, which move between bacteria — even between different species. Resistance genes can also hop around the genome on mobile genetic elements called transposons ("jumping genes") and integrons. This means a single resistant bacterium can pass its resistance not just to its offspring, but to neighboring bacteria — even ones of a completely different species. This is how resistance can spread explosively through a hospital, a community, or across the world.
The Selective Pressure Problem
Every time antibiotics are used — whether appropriately or inappropriately — they create selective pressure that favors resistant bacteria. The sensitive bacteria die, freeing up resources and space for any resistant ones to flourish. This is why overuse and misuse of antibiotics are the single biggest accelerators of resistance. The more we use antibiotics, the faster resistance spreads.
The One Health Connection
Resistance does not respect the boundaries between humans, animals, and the environment. Antibiotics are widely used in livestock farming — both to treat sick animals and, in some countries, to promote growth — and resistant bacteria from animals can spread to humans through food, water, and direct contact. Resistant genes also persist in soil and water. This is why experts describe the AMR challenge through a "One Health" lens: human, animal, and environmental health are inseparable when it comes to resistance.
The Superbugs — Notorious Resistant Pathogens
Some bacteria have become resistant to so many antibiotics that they are effectively "superbugs" — difficult or sometimes impossible to treat. The most concerning are often summarized by the acronym ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species).
MRSA — Methicillin-Resistant Staphylococcus aureus
MRSA is one of the best-known superbugs. Staphylococcus aureus is a common bacterium that lives harmlessly on the skin of many people but can cause serious infections — skin abscesses, bloodstream infections, pneumonia — if it enters the body. MRSA strains are resistant to nearly all penicillin-type antibiotics (beta-lactams), forcing doctors to use alternative drugs such as vancomycin. MRSA causes an estimated more than 120,000 deaths per year worldwide and is a major problem in hospitals, where it can spread between patients.
Carbapenem-Resistant Enterobacteriaceae (CRE)
Some gut bacteria, like Klebsiella and E. coli, have acquired enzymes (such as NDM-1 and KPC) that destroy even carbapenems — powerful antibiotics reserved as a last resort. These carbapenem-resistant bacteria are sometimes resistant to nearly all available antibiotics, leaving doctors with few or no effective options. They have been dubbed "nightmare bacteria" by public health officials.
Multidrug-Resistant Tuberculosis (MDR-TB and XDR-TB)
Tuberculosis (TB) treatment requires months of multiple antibiotics. When TB bacteria become resistant to the two most powerful first-line drugs, the result is MDR-TB (multidrug-resistant TB); when they resist even second-line drugs, it is XDR-TB (extensively drug-resistant TB). These forms are far harder, longer, and more expensive to treat, with much lower cure rates.
Gonorrhea, C. difficile, and Others
Neisseria gonorrhoeae, the bacterium that causes gonorrhea, has progressively developed resistance to every class of antibiotics used to treat it, raising fears of untreatable gonorrhea. Clostridioides difficile is a different kind of problem: it is not strongly resistant itself, but it thrives when antibiotics wipe out the normal gut bacteria, causing severe — sometimes fatal — diarrhea, especially in hospitalized patients.
The Global Scale of the AMR Crisis
The numbers behind antimicrobial resistance are alarming and growing.
1.27 Million Deaths in 2019
The most comprehensive global analysis to date, published in The Lancet in 2022, estimated that bacterial antimicrobial resistance was directly responsible for 1.27 million deaths worldwide in 2019, and was associated with 4.95 million deaths in total. To put that in perspective, resistant infections killed more people than HIV/AIDS (864,000) or malaria (643,000) in that same year. The burden fell hardest on sub-Saharan Africa and South Asia, and on the very young and the very old.
The 10 Million Forecast
A widely cited 2016 review commissioned by the UK government, led by economist Jim O'Neill, projected that if current trends continue, AMR could cause 10 million deaths per year by 2050 — more than cancer — and cost the global economy up to $100 trillion. While the exact projections are debated, the direction is clear: resistance is rising faster than new antibiotics are being developed.
The Pipeline Problem
For decades, pharmaceutical companies have had little financial incentive to develop new antibiotics, because antibiotics are used briefly (unlike drugs for chronic diseases), are held in reserve to preserve their effectiveness, and compete against cheap generics. As a result, the antibiotic pipeline has nearly dried up: the number of new antibiotics approved each year has fallen dramatically since the 1980s. Without new drugs to replace those rendered useless by resistance, the world risks returning to a "post-antibiotic era" in which common infections once again become deadly.
Why AMR Is Called the "Silent Pandemic"
Unlike COVID-19, which exploded into global awareness within weeks, AMR has crept up slowly and largely invisibly. People die of resistant infections one by one in hospitals, not in dramatic waves. But the cumulative death toll already rivals that of major pandemics, and the threat continues to grow. This is why public health leaders describe AMR as a "silent pandemic" — dangerous precisely because it is so easy to ignore.
The Consequences of a Post-Antibiotic Era
If antibiotics lose their effectiveness, the impact would extend far beyond treating infections.
Modern Medicine Depends on Antibiotics
Many of the miracles of modern medicine rely on antibiotics working reliably. Surgery — from routine appendectomies to organ transplants — depends on antibiotics to prevent and treat surgical infections. Chemotherapy for cancer deliberately suppresses the immune system, leaving patients vulnerable to infection; without effective antibiotics, cancer treatment becomes far more dangerous. Childbirth, premature infants, dialysis, and joint replacements all carry infection risks that antibiotics currently control. Lose antibiotics, and much of modern medicine becomes far riskier.
Simple Injuries and Illnesses Become Dangerous Again
Before antibiotics, a scratch from a rose thorn, a dog bite, or strep throat could spiral into a fatal bloodstream infection. In a post-antibiotic world, those everyday risks would return. Routine childhood infections, urinary tract infections, and pneumonia would once again regularly kill people.
Economic and Social Costs
Resistant infections are longer, more severe, and far more expensive to treat — requiring longer hospital stays, costly last-resort drugs, and isolation measures. The economic toll of AMR is projected to be enormous, particularly in lower-income countries where healthcare systems are least able to absorb the cost.
What You Can Do — Preserving Antibiotics
The good news is that everyone — individuals, doctors, farmers, and governments — has a role to play in slowing the spread of resistance. Here is what each of us can do.
Use Antibiotics Only When Needed
Antibiotics should be used only for bacterial infections, prescribed by a healthcare provider, and only when truly necessary. They do not work against viruses, so demanding antibiotics for a cold or the flu is counterproductive. Always follow your doctor's guidance.
Take Antibiotics Exactly as Prescribed
When you do need antibiotics, take them exactly as directed — the right dose, at the right intervals, for the full prescribed duration. Do not stop early just because you feel better, unless your doctor tells you to. Stopping too soon can allow the most resistant bacteria to survive and rebound.
Never Save or Share Antibiotics
Never take leftover antibiotics from a previous illness, and never share antibiotics with others. Antibiotics are chosen specifically for a particular infection and person; using the wrong drug can be ineffective or harmful.
Prevent Infections in the First Place
The best way to reduce antibiotic use is to avoid infections — through handwashing, safe food preparation, safe sex, and vaccination. Vaccines reduce the number of bacterial infections (such as pneumococcal and meningococcal disease) and the secondary bacterial infections that can follow viral illnesses, all of which reduces the need for antibiotics.
Support Responsible Use in Agriculture
Because agricultural antibiotic use contributes to resistance, supporting policies and products that promote responsible antibiotic use in farming — and avoiding the routine use of antibiotics for growth promotion — matters on a global scale.
Spread Awareness
Many people still misunderstand what antibiotics do and do not do. Simply understanding that antibiotics cannot treat viral infections — and sharing that understanding — is one of the most powerful tools against resistance.
FAQ
Do antibiotics work against colds and the flu?
No. Antibiotics kill or inhibit bacteria, but colds, the flu (influenza), most sore throats, COVID-19, and most cases of acute bronchitis are caused by viruses. Viruses have no cell wall and no independent metabolism, so they are unaffected by antibiotics. Taking an antibiotic for a viral infection provides no benefit, exposes you to side effects (including disrupting your normal bacteria), and — most importantly — fuels antibiotic resistance by killing sensitive bacteria and allowing resistant ones to flourish. Antiviral drugs, not antibiotics, are used to treat certain viral infections.
How do bacteria become resistant to antibiotics?
Bacteria develop resistance through natural selection combined with several molecular mechanisms. When an antibiotic is used, sensitive bacteria die, while any bacterium carrying a resistance advantage survives and multiplies. Resistance mechanisms include: (1) enzymatic inactivation — producing enzymes like beta-lactamase that destroy the drug; (2) target modification — changing the bacterial molecule the drug targets so it no longer binds; (3) efflux pumps — actively pumping the drug out of the cell; and (4) reduced permeability — altering the outer membrane to keep the drug out. Bacteria can also acquire resistance genes from other bacteria through horizontal gene transfer via plasmids, transposons, and integrons — sometimes even between different species.
What is MRSA?
MRSA (methicillin-resistant Staphylococcus aureus) is one of the most common and dangerous superbugs. Staphylococcus aureus is a bacterium many people carry harmlessly on their skin, but it can cause serious infections if it enters the body. MRSA strains are resistant to nearly all penicillin-type (beta-lactam) antibiotics because they acquired a new cell-wall enzyme (PBP2a, from the mecA gene) that these drugs cannot block. MRSA infections are treated with alternative antibiotics such as vancomycin, linezolid, or daptomycin. MRSA causes over 120,000 deaths per year worldwide and is a particular problem in hospitals, where it spreads between patients.
Why can't I stop taking antibiotics when I feel better?
You should always finish your full prescribed course of antibiotics unless your doctor tells you otherwise. When you start an antibiotic, it kills the most sensitive bacteria first, and you start feeling better as their numbers drop. But the most resistant bacteria may still be alive, and stopping the drug early can allow them to survive, multiply, and cause a relapse — or spread to others. Completing the full course ensures that even the more resistant bacteria are eliminated, reducing the chance that a hard-to-treat infection rebounds.
How serious is antibiotic resistance?
Antibiotic resistance is one of the top global public health threats. A major 2022 study estimated that bacterial antimicrobial resistance was directly responsible for 1.27 million deaths worldwide in 2019 and associated with nearly 5 million deaths in total — more than HIV/AIDS or malaria. If current trends continue, projections suggest AMR could cause up to 10 million deaths per year by 2050. Beyond the death toll, losing effective antibiotics would make surgeries, cancer treatment, and childbirth far more dangerous, because modern medicine depends on the ability to prevent and treat bacterial infections.
Can antibiotic resistance be reversed?
It is difficult but not impossible to slow or partially reverse resistance. When antibiotic use is reduced, the selective pressure favoring resistant bacteria is lifted, and sensitive bacteria can sometimes regain a competitive advantage. However, resistance genes often persist at low levels for a long time and can resurface if antibiotic use rises again. This is why the most effective strategy is prevention: using antibiotics responsibly, developing new drugs and alternative treatments (such as bacteriophage therapy and vaccines), improving infection control, and coordinating action across human and animal health. Resistance is a natural evolutionary process we cannot eliminate, but we can — and must — slow it dramatically.
References
- Fleming A: On the antibacterial action of cultures of a penicillium — the 1928 discovery of penicillin (British Journal of Experimental Pathology, 1929; Fleming's 1945 Nobel lecture on resistance).
- Chain E, Florey HW, and colleagues: Penicillin as a chemotherapeutic agent — purification and clinical development (The Lancet, 1940; Nobel Prize 1945).
- Murray CJL et al (GBD 2019 AMR Collaborators): Global burden of bacterial antimicrobial resistance in 2019 — 1.27 million deaths attributable to AMR (The Lancet, 2022).
- O'Neill J: Tackling Drug-Resistant Infections Globally — the UK Review on Antimicrobial Resistance, projecting 10 million deaths per year by 2050 (2016).
- World Health Organization (WHO): Antimicrobial resistance — global threat and fact sheets (updated 2024).
- Centers for Disease Control and Prevention (CDC): Antibiotic/Antimicrobial Resistance — threats, mechanisms, and antibiotic stewardship (updated 2024).
- Reygaert WC: An overview of the antimicrobial resistance mechanisms of bacteria — beta-lactamases, efflux pumps, biofilms, and target modification (AIMS Microbiology; updated reviews 2023).
- Foster SJ et al: MRSA's double defense mechanism against antibiotics — methicillin resistance and alternative cell division (Science, 2024).
- Aminov RI: A brief history of the antibiotic era — from sulfonamides to the modern era and the rise of resistance (Frontiers in Microbiology; updated reviews 2022).
- European Centre for Disease Prevention and Control (ECDC) and One Health AMR initiatives: Surveillance and stewardship in human and animal health (updated 2024).
This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Never take antibiotics without a prescription, and always follow your healthcare provider's instructions. If you have an infection or questions about antibiotics, please consult a qualified healthcare provider.